Fig. 6From: Leveraging 3D chemical similarity, target and phenotypic data in the identification of drug-protein and drug-adverse effect associationsIntersection of drug-adverse effect and target-adverse effect data (a). Precision (b) and Enrichment Factor (c) in drug-adverse effect identification comparing the 3D drug-adverse effect model leveraged with target data with the 3D drug-adverse effect model by itselfBack to article page